| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |